¿À´Ã ÇÏ·ç ±×¸¸º¸±â
´Ý±â
·Î±×ÀÎ
|
ȸ¿ø°¡ÀÔ
|
ID/PW ã±â
|
Á¦Ç°»ó´ã¹®ÀÇ
°í°´Áö¿ø
¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
ÀüȹøÈ£¦¢
02-2081-2510
Email ¦¢
support@takara.co.kr
´ëÀüÁö»ç
¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
ÀüȹøÈ£¦¢
042-828-6525
Email ¦¢
tkbd@takara.co.kr
¾÷¹«½Ã°£¾È³»
[ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Á¦Ç°Á¤º¸
°øÁö
±â¼úÁö¿ø
Á¤º¸ÀÚ·á
Learning Center
ȸ»çÁ¤º¸
ÀüÁ¦Ç°º¸±â
Á¦Ç°¼±Åð¡À̵å
Custom Service
À̺¥Æ®/ÇÁ·Î¸ð¼Ç
´ÙÄ«¶ó¼Ò½Ä
Takara Bio°ø½Ã
½ÅÁ¦Ç°¾È³»
¶óÀ̼±½º¾È³»
±â¼úÁö¿ø¹®ÀÇ
±â±âµ¥¸ð½Åû
¼¼¹Ì³ª½Åû
LMO¾È³»
ºê·Î¼Å
On-line tool
eNews
樨毢
CoA & MSDS
°³¿ä & ¸®½ºÆ®
¼Ò°³
µµÀԺ귣µå Á¤º¸
´ë¸®Á¡Á¤º¸
ã¾Æ¿À½Ã´Â±æ
Home
>
ÀüÁ¦Ç°º¸±â
>
¼¼Æ÷¤ýÀ¯ÀüÀÚ Ä¡·á ¿¬±¸
>
Gene editing
> Recombinant Cas9 ´Ü¹éÁú
Recombinant Cas9 ´Ü¹éÁú
Á¦Á¶»ç
Á¦Ç°ÄÚµå
Á¦Ç°¸í
¿ë·®
°¡°Ý
(ºÎ°¡¼¼º°µµ)
ºñ°í
»ç¿ëÀڸŴº¾ó
Clontech
632640
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)
3x100 ug (632641 x 3)
903,000¿ø
Clontech
632641
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)
100 ug
334,000¿ø
Product index
Overview
RetroNectin¢ç - Viral ..
[FAQ] Retronectin
RetroNectin¢çÀÇ ´Ù¾çÇÑ..
T cell ¿¬±¸ÀÚ¸¦ À§ÇÑ ..
[Cancer Research] Immu..
Cancer ¿¬±¸ °¡À̵å
T cell therapy ¿¬±¸
RetroNectin¢ç (Recombi..
Anti-CD3 mAb GMP grade
LymphoONE¢ç T-Cell Exp..
Cytokine GoStix¢â Plus..
GT-T551 Culture medium
¼¼Æ÷ ¹è¾ç¿ë °¡½º Åõ°ú..
Gene editing
Recombinant Cas9 ´Ü¹é..
sgRNA ÇÕ¼º°ú ½ºÅ©¸®´×
TransIT-X2¢ç Transfect..
[Upgrade] Guide-it¢â L..
TCR/BCR Profiling
Human TCR a/b Profilin..
Mouse TCR a/b Profilin..
Mouse BCR IgG H/K/L Pr..
¼¼Æ÷¹è¾ç °ü·Ã Á¦Ç°
Cell culture ÇʼöÇ° - ..
¼¼Æ÷¹è¾ç½Ã Mycoplasma ..
MycoAlert PLUS mycopla..
MycoAlert Mycoplasma D..
MycoZap Antibiotics
MycoZap Mycoplasma Eli..
TaKaRa PCR Mycoplasma ..
CycleavePCR Mycoplasma..
Ç×»ýÁ¦ ½Ã¸®Áî I
Phosphate Buffered Sal..
TBS(Tris-Buffered Sali..
The Cas9 protein solution is sterile and well-tolerated by mammalian cells
Highly efficient editing when combined with
Guide-it Complete sgRNA Screening System (Code 632636)
Minimizes off-target effects-better than plasmid-based delivery systems
Works well in hard-to-transfect cell lines
Á¦Ç°¼³¸í
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)Àº
Streptococcus pyogenes
À¯·¡ÀÇ Cas9 ÀçÁ¶ÇÕ ´Ü¹éÁú·Î½á CRISPR/Cas9 gene editing ½ÇÇè¿¡ »ç¿ëÇÒ ¼ö ÀÖµµ·Ï C-terminal nuclear-localization signal (NLS) º¯ÇüÀÌ µÇ¾î ÀÖ´Ù. Cas9-sgRNA ribonucleoprotein(RNP) º¹ÇÕüÀÇ electroporationÀº ºü¸¥ ½Ã°£ ³» gene editingÀÌ °¡´ÉÇϵµ·Ï Çϸç, ¶ÇÇÑ off-target effect¸¦ ÃÖ¼ÒÈ ÇÒ ¼ö ÀÖ´Ù.
º» Á¦Ç°Àº Transfection ½Ã¾à¿¡ ÀÇÇÑ RNP delivery¿¡µµ Àû¿ë °¡´ÉÇϸç, ÀÌ °æ¿ì MirusÀÇ
TransIT-X2 Dynamic Delivery System (Code MIR 6000)
»ç¿ëÀ» ÃßõÇÑ´Ù (±×¸² 4. ÂüÁ¶)
±×¸² 1. Gene knockouts in the Cellartis hiPSC-18 cell line.
The strength of the cleaved bands gives a semiquantitive estimate of the percentage of edited cells. As can be seen, the Guide-it recombinant Cas9, when combined with sgRNA from the Guide-it
In Vitro
Transcription Kit, provides consistent and effective gene editing for many targets. Numbers at the bottom of each gel represent gene editing efficiencies (expressed as a %) for the indicated RNPs.
±×¸² 2. Homology-directed repair at the AAVS1 or CXCR4 genes.
A template containing a HindIII restriction site was inserted into the AAVS1 gene, and a template containing both a HindIII and a BamHI restrictrion site was inserted into the CXCR4 gene. Gene targets were then amplified from target cells using PCR and analyzed by restriction digest. Editing efficiencies are shown above each positive well on the gel. The extra band in the BamHI digest of the CXCR4 gene is due to a second BamHI site already present in the wild-type gene before editing.
±×¸² 3.
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)°ú Ÿ»ç Cas9 ´Ü¹éÁúÀÇ Konck-out È¿À² ºñ±³
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)°ú Ÿ»çÀÇ Cas9 proteinÀ» ÀÌ¿ëÇÏ¿©, Human iPS cell¿¡¼ CD81 À¯ÀüÀÚ¸¦ Ÿ°ÙÇÏ´Â sgRNA-Cas9 RNP º¹ÇÕü¸¦ Neon Transfection System (Thermo Fisher Scientific)À¸·Î Electroporation µµÀÔÇÏ¿´´Ù. ±× °á°ú, Ÿ»çÀÇ Cas9 ´Ü¹éÁú¿¡ ºñÇÏ¿© ¿ùµîÈ÷ ³ôÀº Knock-out È¿À²À» ¾òÀ» ¼ö ÀÖ¾ú´Ù (ÀÚ»ç ½ÇÇèµ¥ÀÌÅÍ, n=2x3 times)
±×¸² 4. Guide-it¢â Recombinant Cas9 (Electroporation-Ready)¿Í TransIT-X2¸¦ ÀÌ¿ëÇÑ iPS cell gene editing
PPIB (Cyclophili B)¿¡ ´ëÇÑ 2°³ÀÇ guide RNA (gRNA)¿Í Cas9 protein (Ÿ»ç Á¦Ç° ¶Ç´Â Guide-it Recombinant Cas9 protein) º¹ÇÕü (RNP)¸¦ Çü¼ºÇÏ¿´´Ù. ±× ÈÄ, RNP º¹ÇÕü¸¦
TransIT-X2 Dynamic Delivery System (Code MIR 6000)
(1§¡/well ÷°¡, 24-well plate, Mirus Bio) ¸¦ ÀÌ¿ëÇÏ¿© iPS cell (KOLF-2, Wellcome Trust Sanger Institute)¿¡ Transfection ¹æ½ÄÀ¸·Î µµÀÔÇÏ¿´´Ù. ¿©·¯ ³óµµÀÇ guide RNA¸¦ Á¶ÇÕÇÑ RNP º¹ÇÕü µµÀÔ ÈÄ, T7E1 mismatch detectionÀ¸·Î Àý´Ü È¿À²À» È®ÀÎÇÑ °á°ú Ÿ»ç Á¦Ç° ´ëºñÇÏ¿© º¸´Ù ³ôÀº Àý´ÜÈ¿À²À» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù.
°ü·Ã Á¦Ç°
Guide-it Complete sgRNA Screening System (Code 632636)
- Gene delivery¿¡ Àû¿ë°¡´ÉÇÑ 10-20ugÀÇ °í¼öÀ², °í¼øµµ sgRNA ÇÕ¼º
- sgRNA candidates Áß °¡Àå editing È¿À²ÀÌ ³ôÀº sgRNA ½ºÅ©¸®´×
TransIT-X2 Dynamic Delivery System (Code MIR 6000)
- DNA, siRNA, miRNA °¢°¢ ¶Ç´Â Co-transfection °¡´ÉÇÑ ¸¸´É Transfection ½Ã¾à
- CRISPR/Cas9À» À§ÇÑ sgRNA-Cas9 RNP delivery¿¡µµ È¿À²Àû
Application Note
TransIT-X2 Dynamic Delivery System (Code MIR 6000)À» ÀÌ¿ëÇÑ Genome Editing ¿¹½Ã
-
293T Cell Line Àû¿ë ¿¹½Ã (Ŭ¸¯)
-
K562 Cell Line Àû¿ë ¿¹½Ã (Ŭ¸¯)
-
Human iPS Cell Àû¿ë ¿¹½Ã (Ŭ¸¯)
Keyword : CRISPR,Cas9 protein,CRISPR/Cas9,CRISPR-Cas9,Å©¸®½ºÆÛ,gene editing,sgRNA, rcas9, cas9 protein, RNP, Ribonucleoprotein, Ribonucleo-protein
Gene editing
Recombinant Cas9 ´Ü¹éÁú
sgRNA ÇÕ¼º°ú ½ºÅ©¸®´×
Trans
IT-X2¢ç Transfection Reagent
À¯ÀüÀÚ »ðÀÔÀ» À§ÇÑ donor template ÇÕ¼º (5 kb..
[Upgrade] Guide-it¢â Long ssDNA Production System v2